{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:22:20Z","timestamp":1790018540987,"version":"4.0.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67752-y","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:33:55Z","timestamp":1767954835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antisense oligonucleotides to KIF1A polymorphisms expand targets and rescue patient-derived neurons in vitro"],"prefix":"10.1038","volume":"17","author":[{"given":"Michael V.","family":"Zuccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randee E.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lanzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Semenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3678-1674","authenticated-orcid":false,"given":"Xiaoqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Skowronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1299-5979","authenticated-orcid":false,"given":"Yufeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6096-8601","authenticated-orcid":false,"given":"Danny E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sarmiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-5050","authenticated-orcid":false,"given":"Charles A.","family":"LeDuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-5685","authenticated-orcid":false,"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"67752_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.yexcr.2004.08.010","volume":"301","author":"N Hirokawa","year":"2004","unstructured":"Hirokawa, N. & Takemura, R. Kinesin superfamily proteins and their various functions and dynamics. Exp. Cell Res 301, 50\u201359 (2004).","journal-title":"Exp. Cell Res"},{"key":"67752_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.147.3.493","volume":"147","author":"N Pollock","year":"1999","unstructured":"Pollock, N., de Hostos, E. L., Turck, C. W. & Vale, R. D. Reconstitution of membrane transport powered by a novel dimeric kinesin motor of the Unc104\/KIF1A family purified from Dictyostelium. J. Cell Biol. 147, 493\u2013506 (1999).","journal-title":"J. Cell Biol."},{"key":"67752_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0092-8674(95)90538-3","volume":"81","author":"Y Okada","year":"1995","unstructured":"Okada, Y., Yamazaki, H., Sekine-Aizawa, Y. & Hirokawa, N. The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell 81, 769\u2013780 (1995).","journal-title":"Cell"},{"key":"67752_CR4","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1126\/science.1073386","volume":"297","author":"M Tomishige","year":"2002","unstructured":"Tomishige, M., Klopfenstein, D. R. & Vale, R. D. Conversion of Unc104\/KIF1A kinesin into a processive motor after dimerization. Science 297, 2263\u20132267 (2002).","journal-title":"Science"},{"key":"67752_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajhg.2011.02.001","volume":"88","author":"FF Hamdan","year":"2011","unstructured":"Hamdan, F. F. et al. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am. J. Hum. Genet 88, 306\u2013316 (2011).","journal-title":"Am. J. Hum. Genet"},{"key":"67752_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113795119","volume":"119","author":"Y Anazawa","year":"2022","unstructured":"Anazawa, Y., Kita, T., Iguchi, R., Hayashi, K. & Niwa, S. De novo mutations in KIF1A-associated neuronal disorder (KAND) dominant-negatively inhibit motor activity and axonal transport of synaptic vesicle precursors. Proc. Natl. Acad. Sci. 119, e2113795119 (2022).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"67752_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang, E. J. & Reichardt, L. F. Neurotrophins: Roles in Neuronal Development and Function1. Annu. Rev. Neurosci. 24, 677\u2013736 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"67752_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","volume":"72","author":"EJ Huang","year":"2003","unstructured":"Huang, E. J. & Reichardt, L. F. Trk Receptors: Roles in Neuronal Signal Transduction*. Annu. Rev. Biochem. 72, 609\u2013642 (2003).","journal-title":"Annu. Rev. Biochem."},{"key":"67752_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jocn.2018.10.091","volume":"61","author":"D Samanta","year":"2019","unstructured":"Samanta, D. & Gokden, M. PEHO syndrome: KIF1A mutation and decreased activity of mitochondrial respiratory chain complex. J. Clin. Neurosci. 61, 298\u2013301 (2019).","journal-title":"J. Clin. Neurosci."},{"key":"67752_CR10","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1007\/s00415-015-7899-9","volume":"262","author":"A Citterio","year":"2015","unstructured":"Citterio, A. et al. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis. J. Neurol. 262, 2684\u20132690 (2015).","journal-title":"J. Neurol."},{"key":"67752_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajhg.2011.06.013","volume":"89","author":"J-B Rivi\u00e8re","year":"2011","unstructured":"Rivi\u00e8re, J.-B. et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am. J. Hum. Genet 89, 219\u2013230 (2011).","journal-title":"Am. J. Hum. Genet"},{"key":"67752_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12999-9","volume":"7","author":"CK Cheon","year":"2017","unstructured":"Cheon, C. K. et al. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene. Sci. Rep. 7, 12527 (2017).","journal-title":"Sci. Rep."},{"key":"67752_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/genes14050972","volume":"14","author":"J Paprocka","year":"2023","unstructured":"Paprocka, J. et al. Expanding the Knowledge of KIF1A-Dependent Disorders to a Group of Polish Patients. Genes (Basel) 14, 972 (2023).","journal-title":"Genes (Basel)"},{"key":"67752_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","volume":"50","author":"CF Bennett","year":"2010","unstructured":"Bennett, C. F. & Swayze, E. E. RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform. Annu. Rev. Pharmacol. Toxicol. 50, 259\u2013293 (2010).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"67752_CR15","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41591-024-03197-y","volume":"30","author":"A Ziegler","year":"2024","unstructured":"Ziegler, A. et al. Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nat. Med 30, 2782\u20132786 (2024).","journal-title":"Nat. Med"},{"key":"67752_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"67752_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2741\/2558","volume":"13","author":"MJ Robertson","year":"2008","unstructured":"Robertson, M. J., Gip, P. & Schaffer, D. V. Neural stem cell engineering: directed differentiation of adult and embryonic stem cells into neurons. Front Biosci. 13, 21\u201350 (2008).","journal-title":"Front Biosci."},{"key":"67752_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y. & Danbolt, N. C. Glutamate as a neurotransmitter in the healthy brain. J. Neural Transm. (Vienna) 121, 799\u2013817 (2014).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"67752_CR19","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.3390\/ijms22094592","volume":"22","author":"J-H Chuang","year":"2021","unstructured":"Chuang, J.-H., Yang, W.-C. & Lin, Y. Glutamatergic Neurons Differentiated from Embryonic Stem Cells: An Investigation of Differentiation and Associated Diseases. Int J. Mol. Sci. 22, 4592 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"67752_CR20","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3390\/molecules25082000","volume":"25","author":"C-Y Chang","year":"2020","unstructured":"Chang, C.-Y. et al. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening. Molecules 25, 2000 (2020).","journal-title":"Molecules"},{"key":"67752_CR21","doi-asserted-by":"crossref","unstructured":"Young, R. E. et al. Pathogenic PPP2R5D variants disrupt neuronal development and neurite outgrowth in patient-derived neurons that are reversed by allele-specific knockdown. HGG Adv. 61, 100450 (2025).","DOI":"10.1016\/j.xhgg.2025.100450"},{"key":"67752_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"Genomes Project Consortium","year":"2015","unstructured":"Genomes Project Consortium et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"67752_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/00005072-199811000-00003","volume":"57","author":"DD Armstrong","year":"1998","unstructured":"Armstrong, D. D., Dunn, K. & Antalffy, B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol. 57, 1013\u20131017 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"67752_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/BF00294247","volume":"79","author":"I Ferrer","year":"1990","unstructured":"Ferrer, I. & Gullotta, F. Down\u2019s syndrome and Alzheimer\u2019s disease: dendritic spine counts in the hippocampus. Acta Neuropathol. 79, 680\u2013685 (1990).","journal-title":"Acta Neuropathol."},{"key":"67752_CR25","first-page":"100026","volume":"2","author":"L Boyle","year":"2021","unstructured":"Boyle, L. et al. Genotype and defects in microtubule-based motility correlate with clinical severity in KIF1A-associated neurological disorder. HGG Adv. 2, 100026 (2021).","journal-title":"HGG Adv."},{"key":"67752_CR26","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.ymthe.2017.06.002","volume":"25","author":"X-H Liang","year":"2017","unstructured":"Liang, X.-H., Sun, H., Nichols, J. G. & Crooke, S. T. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus. Mol. Ther. 25, 2075\u20132092 (2017).","journal-title":"Mol. Ther."},{"key":"67752_CR27","doi-asserted-by":"publisher","first-page":"17181","DOI":"10.1074\/jbc.M311683200","volume":"279","author":"H Wu","year":"2004","unstructured":"Wu, H. et al. Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J. Biol. Chem. 279, 17181\u201317189 (2004).","journal-title":"J. Biol. Chem."},{"key":"67752_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007902","volume":"15","author":"M Rigau","year":"2019","unstructured":"Rigau, M., Juan, D., Valencia, A. & Rico, D. Intronic CNVs and gene expression variation in human populations. PLoS Genet 15, e1007902 (2019).","journal-title":"PLoS Genet"},{"key":"67752_CR29","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.molcel.2019.12.029","volume":"77","author":"F Lai","year":"2020","unstructured":"Lai, F., Damle, S. S., Ling, K. K. & Rigo, F. Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination. Mol. Cell 77, 1032\u20131043.e4 (2020).","journal-title":"Mol. Cell"},{"key":"67752_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.molcel.2020.02.010","volume":"77","author":"DG Maranon","year":"2020","unstructured":"Maranon, D. G. & Wilusz, J. Mind the Gapmer: Implications of Co-transcriptional Cleavage by Antisense Oligonucleotides. Mol. Cell 77, 932\u2013933 (2020).","journal-title":"Mol. Cell"},{"key":"67752_CR31","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1038\/s41380-023-02035-w","volume":"28","author":"G Yang","year":"2023","unstructured":"Yang, G. et al. Neurite outgrowth deficits caused by rare PLXNB1 mutation in pediatric bipolar disorder. Mol. Psychiatry 28, 2525\u20132539 (2023).","journal-title":"Mol. Psychiatry"},{"key":"67752_CR32","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1523\/JNEUROSCI.0642-19.2019","volume":"39","author":"KD Winden","year":"2019","unstructured":"Winden, K. D. et al. Biallelic Mutations in TSC2 Lead to Abnormalities Associated with Cortical Tubers in Human iPSC-Derived Neurons. J. Neurosci. 39, 9294\u20139305 (2019).","journal-title":"J. Neurosci."},{"key":"67752_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/brain\/awaa387","volume":"144","author":"L Rossini","year":"2021","unstructured":"Rossini, L. et al. Dendritic pathology, spine loss and synaptic reorganization in human cortex from epilepsy patients. Brain 144, 251\u2013265 (2021).","journal-title":"Brain"},{"key":"67752_CR34","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1528-1157.1994.tb02503.x","volume":"35","author":"P Multani","year":"1994","unstructured":"Multani, P., Myers, R. H., Blume, H. W., Schomer, D. L. & Sotrel, A. Neocortical dendritic pathology in human partial epilepsy: a quantitative Golgi study. Epilepsia 35, 728\u2013736 (1994).","journal-title":"Epilepsia"},{"key":"67752_CR35","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1038\/s41380-021-01155-5","volume":"26","author":"ML Mignogna","year":"2021","unstructured":"Mignogna, M. L. et al. RAB39B-mediated trafficking of the GluA2-AMPAR subunit controls dendritic spine maturation and intellectual disability-related behaviour. Mol. Psychiatry 26, 6531\u20136549 (2021).","journal-title":"Mol. Psychiatry"},{"key":"67752_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B","volume":"98","author":"SA Irwin","year":"2001","unstructured":"Irwin, S. A. et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am. J. Med Genet 98, 161\u2013167 (2001).","journal-title":"Am. J. Med Genet"},{"key":"67752_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1528-1167.2012.03486.x","volume":"53","author":"RF Berman","year":"2012","unstructured":"Berman, R. F., Murray, K. D., Arque, G., Hunsaker, M. R. & Wenzel, H. J. Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation. Epilepsia 53, 150\u2013160 (2012).","journal-title":"Epilepsia"},{"key":"67752_CR38","doi-asserted-by":"publisher","first-page":"e26203","DOI":"10.1371\/journal.pone.0026203","volume":"6","author":"SD Sheridan","year":"2011","unstructured":"Sheridan, S. D. et al. Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome. PLoS One 6, e26203 (2011).","journal-title":"PLoS One"},{"key":"67752_CR39","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1089\/scd.2014.0030","volume":"23","author":"ME Doers","year":"2014","unstructured":"Doers, M. E. et al. iPSC-Derived Forebrain Neurons from FXS Individuals Show Defects in Initial Neurite Outgrowth. Stem Cells Dev. 23, 1777\u20131787 (2014).","journal-title":"Stem Cells Dev."},{"key":"67752_CR40","doi-asserted-by":"publisher","first-page":"17834","DOI":"10.1073\/pnas.0508995102","volume":"102","author":"M Castr\u00e9n","year":"2005","unstructured":"Castr\u00e9n, M. et al. Altered differentiation of neural stem cells in fragile X syndrome. Proc. Natl. Acad. Sci. USA 102, 17834\u201317839 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67752_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-019-0311-3","volume":"11","author":"P Martin","year":"2020","unstructured":"Martin, P. et al. TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling. Mol. Autism 11, 2 (2020).","journal-title":"Mol. Autism"},{"key":"67752_CR42","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/mp.2017.86","volume":"23","author":"N Mellios","year":"2018","unstructured":"Mellios, N. et al. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling. Mol. Psychiatry 23, 1051\u20131065 (2018).","journal-title":"Mol. Psychiatry"},{"key":"67752_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72791-4","volume":"14","author":"A Balogh","year":"2024","unstructured":"Balogh, A. et al. Establishment of human pluripotent stem cell-derived cortical neurosphere model to study pathomechanisms and chemical toxicity in Kleefstra syndrome. Sci. Rep. 14, 22572 (2024).","journal-title":"Sci. Rep."},{"key":"67752_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2011.01.018","volume":"491","author":"KY Lo","year":"2011","unstructured":"Lo, K. Y., Kuzmin, A., Unger, S. M., Petersen, J. D. & Silverman, M. A. KIF1A is the primary anterograde motor protein required for the axonal transport of dense-core vesicles in cultured hippocampal neurons. Neurosci. Lett. 491, 168\u2013173 (2011).","journal-title":"Neurosci. Lett."},{"key":"67752_CR45","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1600-0854.2006.00442.x","volume":"7","author":"J de Wit","year":"2006","unstructured":"de Wit, J., Toonen, R. F., Verhaagen, J. & Verhage, M. Vesicular trafficking of semaphorin 3A is activity-dependent and differs between axons and dendrites. Traffic 7, 1060\u20131077 (2006).","journal-title":"Traffic"},{"key":"67752_CR46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.tins.2015.05.003","volume":"38","author":"P Valnegri","year":"2015","unstructured":"Valnegri, P., Puram, S. V. & Bonni, A. Regulation of Dendrite Morphogenesis by Extrinsic Cues. Trends Neurosci. 38, 439\u2013447 (2015).","journal-title":"Trends Neurosci."},{"key":"67752_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1101\/lm.67804","volume":"11","author":"M Alonso","year":"2004","unstructured":"Alonso, M., Medina, J. H. & Pozzo-Miller, L. ERK1\/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem. 11, 172\u2013178 (2004).","journal-title":"Learn Mem."},{"key":"67752_CR48","unstructured":"BDNF effects on dendritic spine morphology and hippocampal function | Cell Tissue Res. https:\/\/link.springer.com\/article\/10.1007\/s00441-017-2782-x."},{"key":"67752_CR49","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1523\/JNEUROSCI.2229-12.2013","volume":"33","author":"E Alvarez-Baron","year":"2013","unstructured":"Alvarez-Baron, E. et al. RIM3\u03b3 and RIM4\u03b3 are key regulators of neuronal arborization. J. Neurosci. 33, 824\u2013839 (2013).","journal-title":"J. Neurosci."},{"key":"67752_CR50","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1083\/jcb.141.2.431","volume":"141","author":"Y Yonekawa","year":"1998","unstructured":"Yonekawa, Y. et al. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J. Cell Biol. 141, 431\u2013441 (1998).","journal-title":"J. Cell Biol."},{"key":"67752_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/tvst.10.1.23","volume":"10","author":"M Byrne","year":"2021","unstructured":"Byrne, M. et al. Stereochemistry Enhances Potency, Efficacy, and Durability of Malat1 Antisense Oligonucleotides In Vitro and In Vivo in Multiple Species. Transl. Vis. Sci. Technol. 10, 23 (2021).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"67752_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/nat.2020.0847","volume":"30","author":"AT Watt","year":"2020","unstructured":"Watt, A. T., Swayze, G., Swayze, E. E. & Freier, S. M. Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy. Nucleic Acid Ther. 30, 215\u2013228 (2020).","journal-title":"Nucleic Acid Ther."},{"key":"67752_CR53","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3390\/cells12192395","volume":"12","author":"US Haque","year":"2023","unstructured":"Haque, U. S. & Yokota, T. Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide. Cells 12, 2395 (2023).","journal-title":"Cells"},{"key":"67752_CR54","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1093\/nar\/gkac037","volume":"50","author":"P Kandasamy","year":"2022","unstructured":"Kandasamy, P. et al. Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS. Nucleic Acids Res 50, 5401\u20135423 (2022).","journal-title":"Nucleic Acids Res"},{"key":"67752_CR55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40291-021-00573-z","volume":"26","author":"H Yasuhara","year":"2022","unstructured":"Yasuhara, H., Yoshida, T., Sasaki, K., Obika, S. & Inoue, T. Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension. Mol. Diagn. Ther. 26, 117\u2013127 (2022).","journal-title":"Mol. Diagn. Ther."},{"key":"67752_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102237","volume":"35","author":"S Aguti","year":"2024","unstructured":"Aguti, S. et al. Strategies to improve the design of gapmer antisense oligonucleotide on allele-specific silencing. Mol. Ther. Nucleic Acids 35, 102237 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"67752_CR57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143\u20131147 (2007).","journal-title":"Science"},{"key":"67752_CR58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fgene.2019.00426","volume":"10","author":"T Mantere","year":"2019","unstructured":"Mantere, T., Kersten, S. & Hoischen, A. Long-Read Sequencing Emerging in Medical Genetics. Front Genet 10, 426 (2019).","journal-title":"Front Genet"},{"key":"67752_CR59","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/humu.24465","volume":"43","author":"LK Conlin","year":"2022","unstructured":"Conlin, L. K., Aref-Eshghi, E., McEldrew, D. A., Luo, M. & Rajagopalan, R. Long-read sequencing for molecular diagnostics in constitutional genetic disorders. Hum. Mutat. 43, 1531\u20131544 (2022).","journal-title":"Hum. Mutat."},{"key":"67752_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev-genom-101722-103045","volume":"24","author":"PE Warburton","year":"2023","unstructured":"Warburton, P. E. & Sebra, R. P. Long-Read DNA Sequencing: Recent Advances and Remaining Challenges. Annu Rev. Genomics Hum. Genet 24, 109\u2013132 (2023).","journal-title":"Annu Rev. Genomics Hum. Genet"},{"key":"67752_CR61","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll, J. B. et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin. Mol. Ther. 19, 2178\u20132185 (2011).","journal-title":"Mol. Ther."},{"key":"67752_CR62","doi-asserted-by":"publisher","first-page":"e12928","DOI":"10.1111\/tra.12928","volume":"25","author":"N Gariballa","year":"2024","unstructured":"Gariballa, N., Badawi, S. & Ali, B. R. Endoglin mutants retained in the endoplasmic reticulum exacerbate loss of function in hereditary hemorrhagic telangiectasia type 1 (HHT1) by exerting dominant negative effects on the wild type allele. Traffic 25, e12928 (2024).","journal-title":"Traffic"},{"key":"67752_CR63","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsych.2017.01.009","volume":"82","author":"R Ben-Shalom","year":"2017","unstructured":"Ben-Shalom, R. et al. Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures. Biol. Psychiatry 82, 224\u2013232 (2017).","journal-title":"Biol. Psychiatry"},{"key":"67752_CR64","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000170","volume":"3","author":"JL Wagnon","year":"2017","unstructured":"Wagnon, J. L. et al. Loss-of-function variants of SCN8A in intellectual disability without seizures. Neurol. Genet 3, e170 (2017).","journal-title":"Neurol. Genet"},{"key":"67752_CR65","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1523\/JNEUROSCI.1010-21.2021","volume":"41","author":"S Hao","year":"2021","unstructured":"Hao, S. et al. CDKL5 Deficiency Augments Inhibitory Input into the Dentate Gyrus That Can Be Reversed by Deep Brain Stimulation. J. Neurosci. 41, 9031\u20139046 (2021).","journal-title":"J. Neurosci."},{"key":"67752_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0418-y","volume":"15","author":"AM Rice","year":"2017","unstructured":"Rice, A. M. & McLysaght, A. Dosage-sensitive genes in evolution and disease. BMC Biol. 15, 78 (2017).","journal-title":"BMC Biol."},{"key":"67752_CR67","unstructured":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS | New Engl. J. Med. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2204705."},{"key":"67752_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41591-021-01557-6","volume":"28","author":"H Tran","year":"2022","unstructured":"Tran, H. et al. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide. Nat. Med 28, 117\u2013124 (2022).","journal-title":"Nat. Med"},{"key":"67752_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10465","volume":"7","author":"A Sharma","year":"2016","unstructured":"Sharma, A. et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 7, 10465 (2016).","journal-title":"Nat. Commun."},{"key":"67752_CR70","doi-asserted-by":"publisher","first-page":"9634","DOI":"10.1093\/nar\/gkt725","volume":"41","author":"ME \u00d8stergaard","year":"2013","unstructured":"\u00d8stergaard, M. E. et al. Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS. Nucleic Acids Res 41, 9634\u20139650 (2013).","journal-title":"Nucleic Acids Res"},{"key":"67752_CR71","doi-asserted-by":"publisher","first-page":"e107434","DOI":"10.1371\/journal.pone.0107434","volume":"9","author":"NH Skotte","year":"2014","unstructured":"Skotte, N. H. et al. Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients. PLoS One 9, e107434 (2014).","journal-title":"PLoS One"},{"key":"67752_CR72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.omtn.2021.11.015","volume":"27","author":"S Hauser","year":"2022","unstructured":"Hauser, S. et al. Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons. Mol. Ther. Nucleic Acids 27, 99\u2013108 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"67752_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108604","volume":"129","author":"GD Mangano","year":"2022","unstructured":"Mangano, G. D. et al. De novo GRIN2A variants associated with epilepsy and autism and literature review. Epilepsy Behav. 129, 108604 (2022).","journal-title":"Epilepsy Behav."},{"key":"67752_CR74","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-018-1939-3","volume":"137","author":"G Nicolas","year":"2019","unstructured":"Nicolas, G. & Veltman, J. A. The role of de novo mutations in adult-onset neurodegenerative disorders. Acta Neuropathol. 137, 183\u2013207 (2019).","journal-title":"Acta Neuropathol."},{"key":"67752_CR75","doi-asserted-by":"publisher","first-page":"983668","DOI":"10.3389\/fgene.2022.983668","volume":"13","author":"M Mohiuddin","year":"2022","unstructured":"Mohiuddin, M., Kooy, R. F. & Pearson, C. E. De novo mutations, genetic mosaicism and human disease. Front Genet 13, 983668 (2022).","journal-title":"Front Genet"},{"key":"67752_CR76","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/brain\/aww261","volume":"140","author":"A Puschmann","year":"2017","unstructured":"Puschmann, A. et al. Heterozygous PINK1 p.G411S increases risk of Parkinson\u2019s disease via a dominant-negative mechanism. Brain 140, 98\u2013117 (2017).","journal-title":"Brain"},{"key":"67752_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49565-7","volume":"15","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. DNA replication in early mammalian embryos is patterned, predisposing lamina-associated regions to fragility. Nat. Commun. 15, 5247 (2024).","journal-title":"Nat. Commun."},{"key":"67752_CR78","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02676","volume":"3","author":"LD Heckman","year":"2014","unstructured":"Heckman, L. D., Chahrour, M. H. & Zoghbi, H. Y. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice. eLife 3, e02676 (2014).","journal-title":"eLife"},{"key":"67752_CR79","doi-asserted-by":"publisher","first-page":"btad311","DOI":"10.1093\/bioinformatics\/btad311","volume":"39","author":"W De Coster","year":"2023","unstructured":"De Coster, W. & Rademakers, R. NanoPack2: population-scale evaluation of long-read sequencing data. Bioinformatics 39, btad311 (2023).","journal-title":"Bioinformatics"},{"key":"67752_CR80","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"67752_CR81","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s43588-022-00387-x","volume":"2","author":"Z Zheng","year":"2022","unstructured":"Zheng, Z. et al. Symphonizing pileup and full-alignment for deep learning-based long-read variant calling. Nat. Comput Sci. 2, 797\u2013803 (2022).","journal-title":"Nat. Comput Sci."},{"key":"67752_CR82","unstructured":"WhatsHap: fast and accurate read-based phasing - Abstract - Europe PMC. https:\/\/europepmc.org\/article\/ppr\/ppr34011."},{"key":"67752_CR83","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-0716-2819-5_8","volume":"2590","author":"M Martin","year":"2023","unstructured":"Martin, M., Ebert, P. & Marschall, T. Read-Based Phasing and Analysis of Phased Variants with WhatsHap. Methods Mol. Biol. 2590, 127\u2013138 (2023).","journal-title":"Methods Mol. Biol."},{"key":"67752_CR84","doi-asserted-by":"publisher","first-page":"102432","DOI":"10.1016\/j.scr.2021.102432","volume":"54","author":"G Iannello","year":"2021","unstructured":"Iannello, G., Patel, A., Sirabella, D., Corneo, B. & Thaker, V. Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity. Stem Cell Res 54, 102432 (2021).","journal-title":"Stem Cell Res"},{"key":"67752_CR85","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10815-020-01723-8","volume":"37","author":"LZ Safier","year":"2020","unstructured":"Safier, L. Z., Zuccaro, M. V. & Egli, D. Efficient SNP editing in haploid human pluripotent stem cells. J. Assist Reprod. Genet 37, 735\u2013745 (2020).","journal-title":"J. Assist Reprod. Genet"},{"key":"67752_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.519","volume":"2","author":"A Patel","year":"2022","unstructured":"Patel, A. et al. Efficient Cas9-based genome editing using CRISPR analysis webtools in severe early onset obesity patient-derived iPSC. Curr. Protoc. 2, e519 (2022).","journal-title":"Curr. Protoc."},{"key":"67752_CR87","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201909163","volume":"219","author":"T Paniza","year":"2020","unstructured":"Paniza, T. et al. Pluripotent stem cells with low differentiation potential contain incompletely reprogrammed DNA replication. J. Cell Biol. 219, e201909163 (2020).","journal-title":"J. Cell Biol."},{"key":"67752_CR88","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.stem.2019.06.013","volume":"25","author":"I Sagi","year":"2019","unstructured":"Sagi, I. et al. Distinct Imprinting Signatures and Biased Differentiation of Human Androgenetic and Parthenogenetic Embryonic Stem Cells. Cell Stem Cell 25, 419\u2013432.e9 (2019).","journal-title":"Cell Stem Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67752-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:04:12Z","timestamp":1769691852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67752-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67752"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67752-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wendy K. Chung has received research funding from Ovid Therapeutics. Noelle Germaine, Tae Hyun, and Patrick Sarmiere are former employees and consultants of Ovid Therapeutics. Danny E. Miller is on scientific advisory boards at Oxford Nanopore Technologies (ONT) and Basis Genetics, is engaged in a research agreement with ONT, has received research and travel support from ONT, and holds stock options in MyOme and Basis Genetics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1109"}}